EP 0527914 A4 19930811 - NOVEL SYNTHETIC GRF ANALOGS
Title (en)
NOVEL SYNTHETIC GRF ANALOGS
Publication
Application
Priority
US 51905490 A 19900504
Abstract (en)
[origin: WO9116923A1] The present invention relates to novel peptides having therapeutic utility. More specifically, the invention relates to peptide analogs of the naturally occuring peptide, growth hormone-releasing factor (GRF). The invention also relates to therapeutic compositions containing these peptides, and therapeutic methods using these peptides to stimulate the productioin of growth hormone in vivo.
IPC 1-7
IPC 8 full level
A61K 38/04 (2006.01); A61P 5/00 (2006.01); C07K 14/575 (2006.01); C07K 14/60 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 5/00 (2017.12); C07K 14/60 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
- [A] EP 0314866 A2 19890510 - UNIV TULANE [US]
- [X] Therapeutic agents produced by genetic engineering, "Quo Vadis?" Symposium, Sanofi Group, May 29-30, 1985 Toulouse-Labège, France
- See references of WO 9116923A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9116923 A1 19911114; AU 651976 B2 19940811; AU 7882291 A 19911127; CA 2082059 A1 19911105; EP 0527914 A1 19930224; EP 0527914 A4 19930811; JP H06502618 A 19940324
DOCDB simple family (application)
US 9103053 W 19910430; AU 7882291 A 19910430; CA 2082059 A 19910430; EP 91909888 A 19910430; JP 50983991 A 19910430